Making the case for ‘regulatory innovation’ in cancer research 02 Dec 2019 Regulation of new cancer therapies, whilst crucially important, can become a barrier to innovation. Our Policy Adviser, Roya Ziaie, takes a look at the current regulatory landscape and what is needed in the future to ensure innovative treatments find their way to patients as quickly as possible. Find out more Show/Hide
Why rare cancers deserve a greater focus and a more targeted approach 28 Feb 2018 The theme of Rare Disease Day 2018 is research. We asked Professor Winette van der Graaf, Professor of Personalised Oncology at The Institute of Cancer Research, London, to share her experiences of research into rare cancers and how this can improve outcomes for patients. Find out more Show/Hide